We are designers and suppliers of generic and customised inhaler device platforms. Our devices include multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers, no heat no PG vaping devices and devices tailored to cannabinoid delivery to the lungs and nasal cavities. Our customers take our devices and combine them with their drug formulation to make final dosage forms that are supplied to users and patients. We create, develop and supply device platforms for evaluation through to commercial supply. Merxin device platforms save customers money and time to develop, file and market inhaled dosage forms. We take problems away from our customer. We do it so they don’t have to. We are a trusted partner. We are part of the solution.
Our DNA is in the pharma industry: we deliver quality, reliability and efficacy. The Merxin team has a thorough understanding and long history of medical device and pharmaceutical product development. Our reputation is built on excellence and audacity.
Merxin is active in the fields of pharmaceuticals and inhaled cannabinoids therapies (iCTx). We make devices that treat lung diseases such as asthma and cannabis therapies reliable.
Quality is in our veins. Merxin Ltd has been assessed and certified as meeting the requirements of ISO 13485:2016 for the Design, Development and Supply of inhalers. We believe in Quality, we deliver Reliability.
Established in the UK in 2015 and based in King’s Lynn, with manufacturing capacity across the globe and an international client base, we are now adding more products to our portfolio and expanding rapidly, which is why we need you. In March we won the King’s Lynn Mayor’s Business of the Year Award.
Chief Technology Officer and founder of Merxin Ltd. Graham is a chartered engineer and medical device expert with an accomplished track record delivering technology and global projects across R&D and commercial industrialisation. Previous lives include Head of Hardware Development at 3M Health Care, Device Engineering Group Manager at Novartis and Programme Manager at Bespak leading the construction and setting up of the UK's largest clean room manufacturing facility for the Mylan generic Advair DPI platform. Building and leading effective teams and delivering exciting projects proves so much fun that his leisure time is filled with a never-ending series of house renovation projects.
Chief Business officer and founder of Merxin Ltd, Philippe is a formulation expert with a global reputation. Philippe is a fellow of the Woolcock Respiratory Institute at Sydney University, and formerly Executive Director at Actavis Pharma, where he set up their generic inhalation pipeline. He has an enviable track record in developing pMDI, DPI, Nebules, Nasal and soft mist inhalers in both generic and originator companies. Philippe recently founded Anthocan Ltd, a company dedicated to inhaled cannabinoid therapies. Philippe founded Merxin with Graham, where he makes sure Merxin provides devices the markets seek and that Merxin is a sound and successful business where creativity and fun go hand in hand.
Helen Allton is the Quality Manager at Merxin. This involves working closely with all Merxin’s employees to ensure that there are processes in place to ensure the best possible product is provided to our customers and that Merxin retains its ISO13485 certification. As Merxin is a growing business, this also involves working closely with Merxin’s selected supplier base. Helen comes to Merxin with a PhD in Chemistry and a varied career in medical industries. As Quality Manager, Helen is able to indulge her liking to be bossy in a constructive manner.
As Programme Manager at Merxin, Steph oversees timely delivery of Merxin’s key programmes. Steph’s experience as an English Teacher and transition into the medical industry equipped her with the patience, skills and knowledge essential for managing £M budgets, navigating quality and technical solutions with customers, suppliers and the Merxin internal team. Steph has managed development and industrial programmes for medical devices. Steph has recently completed an MSc in Strategic Project Management and is keen to keep learning!
Adam is a Principal Engineer at Merxin with a wealth of experience in inhalation device development and a strong background in mechanical engineering. Adam has a hands-on approach to tackling projects, accomplishing goals and solving complex problems. His creative insight and vision combined with a strong technical skill set have resulted in a proven track record in intellectual property generation and bringing novel products from laboratory concepts to mass-manufacture. As an engineer, Adam is happy to help and explain, although he can't promise the workings of his mind will be understandable.
Emma is based at Merxin Head Office in King’s Lynn where she works closely with and assists Philippe and Graham in their day to day duties, whilst supporting the wider team with all elements of office and company administration within each department. Emma brings with her a wide and varied range of skills and experience, gained across several industries working for both independent and global organisations. Emma is motivated by the busy, demanding and fun Merxin environment, especially when there’s chocolate involved!
Adam is a Design and Development Engineer at Merxin. He has been working in engineering since completing his degree. His experience is in mechanical engineering and he will provide an excellent hands-on approach to developing Merxin Devices. Adams creativity combined with his forward-thinking methods will provide a strong base for the future of Merxin. He is more than qualified to handle the fast-progressive changes that are happening every day at Merxin. Adam is a multi-talented individual able to ride a unicycle and play the drums and is now thinking of using these skills to revamp the Merxin Device Catwalk.
Dylan is a laboratory technician at Merxin Based in our UK office in King’s Lynn. Dylan is a testing expert that brings additional skills to help us deliver world class devices to market. Having worked with inhalation devices in R&D for five years, Dylan has a wealth of experience to jump straight in and support projects and customers. Dylan’s OINDP knowledge equips him to work with Merxin growing range of devices. Dylan looks forward to broadening his knowledge at Merxin and learn the Merxin device development path. Having recently moved to Norfolk from Leicestershire, Dylan has been exploring the fens and forests near King’s Lynn, seeking inspiration in the virgin Norfolk landscape for his own guitar playing adventures, hoping the locals be patient with his budding talent.
Head of Industrialisation
Shaun is Merxin’s Head of Industrialisation. Based in our King’s Lynn Centre, Shaun is responsible for the scale up to commercial status of Merxin’s devices. This includes mould tooling, mould Processing, metrology and assembly. Having worked in various roles from medical device product development to full scale commercialisation projects, Shaun has 25 years of rich experiences in the medical device industry and is well placed to ensure customers’ needs are met. As a qualified toolmaker Shaun is capable of making real the ideas (dreams) of his design and development colleagues, which often requires the gift of mind reading, which is a secret talent he has learned to cultivate while being married and raising his 3 children.
Vinpaul is a Senior Client Relationship Manager at MERXIN. He is involved in driving and supporting strategic initiatives for business development and sales to expand MERXIN’s reach in the OINDP world. Vinpaul has been associated with the inhalation drug delivery industry since 2014. Prior to MERXIN, Vinpaul was heading BD & Sales at Novi Systems (now a Copley Scientific Company) where he expanded the pharmaceutical customer base from UK & Europe to Asia, South America and North America. Vinpaul has an engineering background having achieved a BEng in Electronics and Instrumentation and an MSc in Electronics & Computer Science. When he is not working, he is either watching car reviews, test driving cars or cooking up a masterpiece in the kitchen.
Aurelien is a PhD student at the University of Hertfordshire (UH) sponsored by Merxin through the Hertfordshire Knowledge Exchange Programme (HKEP). Aurelien’s research focusses on investigating soft-mist aerosol generation in support of Merxin’s development of MRX004.
Aurelien studied in France and the UK for his undergraduate and postgraduate qualifications. Before starting a new academic career, Aurelien worked as a Senior Research Assistant in the department of Clinical and Pharmaceutical Sciences at UH. This experience gave Aurelien the opportunity to work on Dry Powder Inhalers, giving him a solid foundation on which to start his PhD focusing on inhalation technology.
After relocating to the UK from France in 2018, Aurelien has dedicated his time to discover the UK in a methodical way that would make the fathers of the Encyclopaedia proud. He has now reached the Cotswolds, Cambridge, Cheddar and Custard, he is hoping to reach King’s Lynn soon.
Vision - Generic & Customised
Merxin is a designer, developer and supplier of generic and customised drug delivery and medical device platforms.
Merxin supplies customers with devices ready to be filled with proprietary formulations. Merxin creates, develops and supplies device platforms for evaluation through to commercial supply.
Merxin device platforms save its customers money and time to develop, file and market inhaled dosage forms. We take problems away from our customer. We do it so they don’t have to. We are a trusted partner. We are part of the solution.
Quality is in our veins. Merxin Ltd has been assessed and certified as meeting the requirements of ISO 13485:2016 for the Design, Development and Supply of inhalers.
Merxin is active in the fields of pharmaceuticals, inhaled cannabinoids therapies (iCTx) and reduced risk nicotine inhalers (RiNih).
The benefits of working with Merxin are:
Ready to use devices with no lengthy nor costly device designing
Reduced project risk
Fast access to standardised device platforms
Recognised and popular technologies
Devices customized to client’s requirements
Possibility for telehealth adaption (DTx, digital therapeutics)
Reduce Cost, Reduce Risk, Increase Success
Merxin's is ISO13485:2016 certified by BSI
MRX003 first commercial manufacturing line ready
MRX001 Approved by the FDA
Merxin wins King’s Lynn and West Norfolk Mayor Business of the year Award
Perlen and Merxin partner to develop BLISTair for Cannabis
MRX001 achieves in vitro bioequivalence against fluticasone+salmeterol DPI reference product
Merxin is the recipient of European Union R&D Funds
MRX003 gets CE marked
Launch of MRX004 soft mist inhaler as a generic device for tiotropium/olodaterol soft mist inhaler
Merxin gets ISO13485:2016 compliance
Merxin moves to King’s Lynn offices
Launch of MRX003 (tiotropium capsule DPI)
Launch of MRX001 (multidose blister dry powder inhaler)
Launch of MRX002, clear pMDI canister
Founding of Merxin Ltd
Awards & Accreditations
In December 2017, Merxin Ltd was assessed and certified as meeting the requirements of ISO 13485:2016 for the Design, Development and Supply of inhalers.
Our ISO 13485:2016 accreditation recognises the quality management systems that Merxin have in place, reflected in the quality of standards across our products and services. Merxin is qualified to supply regulated markets such as the EU, Japan, Canada, Australia and US.
FDA substitutability of MRX003
In February 2017, MRX003, our capsule DPI inhaler was given the nod by the FDA as a suitable generic device with which to file a 505j ANDA of Spiriva HandiHaler (tiotropium).
The origins of Merxin are in the generic world, we design devices that accelerate generic filing: performance and handling are matched to the originator product while avoiding existing I.P. Merxin excels at this. We take this expertise to make device platforms for new molecules and combinations.
CE marking of MRX003
In December 2017, a version of our Capsule inhaler MRX003 was cleared for CE marking and use in clinical trials.
We do not simply design devices, we make them compliant with the necessary device regulations in EU and US, ready for human use, clinical trials and commercial launch. Pharmaceutical quality is in our DNA.
EU Regional Development Fund Grant
In December 2018, Merxin was awarded a grant from the New Anglia Business Growth Programme - Small Grant Scheme, part funded by the European Regional Development Fund.
The funds were used to accelerate Merxin R&D plans and enabled us to invest in new equipment, Malvern Spraytec and Mitutoyo Metrology, to increase our services to our clients.
We are committed to exceed our customers’ expectation and work and run with them towards filing, approval and launch of their products. The commercial success of our clients is the measure of our success.
Business of the Year awards – 2019
In March 2019, Merxin was named as West Norfolk’s top company.
We were awarded the Mayor’s Business of the Year Award 2019 by King’s Lynn and West Norfolk council.
The award recognises ambition, drive, innovation and determination demonstrated by the businesses of West Norfolk and their contribution to the King’s Lynn and West Norfolk economy.
As the leading medical device company in King’s Lynn we want to help grow a high-tech ecosystem reliant on local talent and accessibility.
We are proud to be recognised for our ground-breaking innovation and our ambitious vision for our future in King’s Lynn.
Merxin is always looking for new talent and will be pleased to hear from future team members wanting to join us.
We use a transparent and engaging recruitment process that opens a creative dialogue with candidates. We like candidates, we appreciate the effort they go to when applying for a position at Merxin. We treat them fairly and openly. We communicate with them whatever the outcome.
That means we do not use over rated recruitment databases and we do not engage copycat bland self-styled recruitment executives. Our future employees deserve more than being treated as statistics.
We advertise our vacancies on LinkedIn, Indeed and other major job search websites.